FPR2 and schwannoma: The aim of present study was to investigate early regulation of the protein levels and signaling functionalities of Fpr2 and TLR9 in the RT4 schwannoma cell model after treatment with fMLF as a canonical Fpr2 ligand and its role as a potential molecular stimulus for inflammatory profiling of Schwann cells.